JUSTIN WATKINS: Open Payments
NPI 1780119925 · BRIGHAM CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 23 payments from 13 companies in 2025. Trend: 2023 $465 · 2024 $526 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $67 |
| Indivior Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $54 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Amgen Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: NURTEC ODT, SUBLOCADE, REXULTI, CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, OTEZLA, Veozah.
Industry payments across UT — which companies pay providers there.
